On March 20, 2025, shares of GPT Infraprojects saw a sharp rise, gaining 13.98% to reach ₹108.81 per share on the National Stock Exchange (NSE). The rally was driven by the company’s announcement of securing a new contract worth ₹481.11 crore.

New Contract Details

GPT Infraprojects was selected as the lowest bidder (L1) for a significant project in the South Eastern Railway’s Kharagpur Division. The contract involves building a major bridge (Bridge No. 57) over the Rupnarayan River and developing Kolaghat Station on elevated platforms. The project is part of the Howrah-Kharagpur route and will be executed on an Engineering, Procurement & Construction (EPC) basis.

Stock Performance Over Time

• Recent Gains: The stock has risen nearly 10% in the last 5 days and 0.7% over the past month.
• 6-Month Decline: Shares have fallen 31% in the last 6 months.
• 1-Year Growth: Investors have seen a return of approximately 37% in the past year.

About GPT Infraprojects

GPT Infraprojects is the leading company of the GPT Group, with over 40 years of experience in civil construction. It specialises in EPC projects across roads, bridges, railways, power, and industrial infrastructure. The company is also a key player in manufacturing concrete sleepers, with production units in India and international locations like South Africa, Namibia, and Ghana.

Market Capitalization and 52-Week Range

• The company’s market capitalisation on the NSE stands at ₹1,359.68 crore.
• 52-week high: ₹204 (July 15, 2024)
• 52-week low: ₹74.28 (March 20, 2024)

Current Market Position

At 11:35 AM on March 20, 2025, GPT Infraprojects shares were trading at ₹102.86, up 7.75% from the previous close of ₹95.46 on NSE. Meanwhile, the broader markets were also positive:

• BSE Sensex: Up 445 points (0.59%) at 75,894
• NSE Nifty50: Up 138 points (0.61%) at 23,046

Conclusion

GPT Infraprojects’ latest contract win strengthens its position in the infrastructure sector. Investors remain optimistic about its growth despite recent stock fluctuations.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

 

Gensol Engineering share price fell 4% on March 30, following multiple bulk deals a day earlier. The stock had hit its 5% upper circuit in the previous session but has faced consistent selling pressure, closing lower in 16 of the last 17 sessions.

Bulk Deals and Trading Activity

On March 19, the stock saw heavy trading activity due to bulk deals:

• Buyer: Cinco Stock Vision LLP purchased 3,00,000 shares at ₹224.90.
• Sellers: KLJ Plasticizers Limited sold 3,00,000 shares at ₹248.50, while M M Ceramics and Ferro Alloys offloaded 2,05,000 shares at ₹231.30.
• Mixed Transactions: Mansi Share and Stock Advisors Pvt Ltd both bought and sold shares, selling 2,20,093 shares at ₹224.91 and buying just 54 shares at ₹244.91.
• Additional Seller: Virtue Financial Services Private Limited sold 2,00,000 shares at ₹224.90.

This activity indicates mixed investor sentiment, with prices ranging from ₹224.90 to ₹248.50.

Sharp Decline in Stock Price

After the bulk deals, Gensol share price dropped 4% to ₹238.00, nearly 79% below its all-time high of ₹1,125.75 in June 2024. It also hit a 52-week low of ₹224.45 in the previous session.

The stock has been on a continuous decline, losing 55% in March alone, after falling:

• 27% in February
• 2.5% in January
• Over 5% in December

Over the last year, the stock has lost more than 70% of its value, eroding investor confidence.

Financial Troubles and Leadership Concerns

Investor concerns have grown due to the company’s delayed loan payments and allegations of falsified debt servicing documents, which led to credit rating downgrade by ICRA and CARE.

Adding to the uncertainty, the Chief Financial Officer (CFO) resigned, shaking investor trust further. To improve its financial health, Gensol’s board approved:

• Raising ₹400 crore through Foreign Currency Convertible Bonds (FCCBs).
• Issuing ₹200 crore worth of warrants to promoters.

Asset Sales to Reduce Debt

To cut debt, Gensol announced the sale of:

• 2,997 electric vehicles worth ₹315 crore
• A wholly owned subsidiary for ₹350 crore

Promoters Sell Shares to Reinvest

To generate funds, promoters sold 9,00,000 shares (2.37% of equity), with plans to reinvest the proceeds back into the company. They assured that the funds would be used for business growth and pledged to subscribe to more shares during the June 18, 2024, warrant issuance. After the sale, promoters still hold a 59.70% stake in the company.

Future Plans and Stock Split Proposal

Gensol plans to consider a stock split and explore additional fundraising options, including equity issuance and FCCBs, in its upcoming March 13 board meeting.

About Gensol Engineering

Founded in 2012, Gensol Engineering is part of the Gensol Group and specialises in solar EPC (Engineering, Procurement, and Construction) services. The company was listed on NSE and BSE in 2023.

Conclusion

Gensol Engineering faces a tough phase with heavy losses, financial struggles, and leadership concerns. While fundraising efforts and asset sales aim to stabilise the company, investor confidence remains shaky. The upcoming board meeting on March 13 will be crucial in determining its future course.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Manappuram Finance share price saw an early surge of 2.82% on Thursday, March 20, 2025, reaching an intraday high of ₹220. However, by 10:10 AM, the stock slipped into negative territory, trading 0.35% lower at ₹213.20. Meanwhile, the BSE Sensex was down 0.44%, trading at 75,784.66.

Board Meeting and Fundraising Plans

The stock’s movement is driven by anticipation of the company’s board meeting scheduled for today. The board is expected to discuss raising funds through various methods, including:

• Equity shares, warrants, or other convertible securities
• Debt securities via preferential issues, private placements, QIPs, or rights issues

Manappuram Finance confirmed in an exchange filing that any fundraising would be subject to regulatory approvals. The board will also consider holding an extraordinary general meeting (EGM) to seek shareholder approval for the proposal.

About Manappuram Finance

Manappuram Finance is a NBFC based in Valapad, Thrissur, Kerala. Founded by V. C. Padmanabhan, the company operates over 4,190 branches across 25 states. As of 2024, it employs 51,004 people. In FY23, Manappuram Finance reported a revenue of ₹6,749 crore (approximately US$850 million).

Conclusion

With a strong market presence and plans for potential fundraising, Manappuram Finance continues to strengthen its financial position. Investors await key decisions from today’s board meeting.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Shares of shipbuilding companies like Garden Reach Shipbuilders & Engineers (GRSE), Mazagon Dock Shipbuilders (MDL), and Cochin Shipyard (CSL) continued their upward trend on Thursday, gaining up to 6% in intraday trade on the BSE. Over the past 2 days, these stocks have surged as much as 28%, driven by high trading volumes.

Government’s ₹40,000 Crore Maritime Plan Boosts Sentiment

The rally in shipbuilding stocks comes after reports that the Indian government will soon introduce a ₹40,000 crore plan aimed at boosting shipbuilding, repair, and recycling. This initiative is part of the Sagarmala 2.0 programme, which aims to strengthen maritime infrastructure, enhance coastal trade, and position India as a global leader in shipbuilding. The programme is expected to attract investments worth ₹12 trillion over the next decade.

Under the Sagarmala 1.0 programme, the government has been executing 839 projects worth ₹5.79 trillion, including modernisation, connectivity, and port-led industrialisation. So far, 272 projects have been completed at an investment of ₹1.41 trillion. The first phase of Sagarmala is set to be completed by 2026.

Individual Stock Performance

• GRSE share price surged 6% to ₹1,746.10, gaining 28% in 2 days from ₹1,367.45 on Tuesday. Since March 4, the stock has jumped 44%.
• MDL share price rose 5% to ₹2,764.95, while CSL share price climbed 3% to ₹1,495.80 in intraday trade. Both stocks have gained 17% over the last two trading sessions.

The Indian government’s strong focus on maritime infrastructure will create new opportunities in the shipbuilding sector, particularly in cargo and passenger segments. The government aims to make India one of the top 5 shipbuilding nations by adding 4 million gross tonnage (GRT) of shipbuilding capacity and expanding port handling capacity to 10 billion metric tonnes per year.

Additionally, India is in discussions with leading shipbuilders from South Korea and Japan about collaborating with domestic shipyards. Companies like Cochin Shipyard, Mazagon Dock Shipbuilders, and Garden Reach Shipbuilders are expected to benefit significantly from these efforts.

Conclusion

With India’s strong maritime push, shipbuilding companies stand to gain significantly. Government initiatives and global collaborations could drive long-term growth in the sector.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

TVS Motor Company’s stock will be in focus on March 20 as the company’s board meets to discuss an interim dividend for the financial year ending March 31, 2025.

In a stock exchange filing on March 13, TVS Motor stated, “A board meeting is scheduled for Thursday, March 20, 2025, to consider and declare an interim dividend, if any, for the shareholders for the financial year ending March 31, 2025.”

The company added that details about the dividend amount, record date, and payment date will be shared after the board meeting.

Previously, TVS Motor announced a dividend of ₹8 per share on February 27, 2024, which was paid on March 19, 2024. In January 2023, it declared a ₹5 per share dividend, paid on February 2.

Strong Sales Growth in February 2025

TVS Motor saw a 10% year-on-year (YoY) growth in vehicle sales in February 2025, reaching 4,03,976 units compared to 3,68,424 units in February 2024.

• Two-wheeler sales grew 10% to 3,91,889 units from 3,57,810 units.
• Domestic two-wheeler sales increased 3% to 2,76,072 units from 2,67,502 units.
• Electric vehicle (EV) sales surged 34%, rising to 24,017 units from 17,959 units.
• Two-wheeler exports jumped 16% to 87,670 units from 75,653 units.

TVS Motor Reduces Stake in IFQM

On March 19, TVS Motor announced that its stake in the Indian Foundation for Quality Management (IFQM) dropped to 18.18% after fresh shares were issued to new investors.

Since the company now holds less than 20%, IFQM is no longer classified as an associate company of TVS Motor under the Companies Act, 2013.

Stock Performance and Market Reaction

As of 9:53 AM IST on March 20, TVS Motor Company share price is trading at ₹2,346.80, up ₹27.05 or 1.17% for the day. The stock opened at ₹2,348.15, reaching a high of ₹2,352.85 and a low of ₹2,335.05. 

The stock’s 52-week high stands at ₹2,958.00, while its 52-week low is ₹1,873.00. Over the past 6 months, the stock has declined by 16.74%, dropping ₹471.35. However, it has gained 15.20% in the past year, rising ₹309.30. Over the last 5 years, TVS Motor’s stock has surged 517.23%, adding ₹1,964.45 to its value.

Despite being 21.5% below its peak, the stock has climbed 24% from its lowest point in the past year. Investors will be watching closely for the outcome of the board meeting and its impact on stock movement.

Conclusion

With strong sales growth and a possible interim dividend, TVS Motor remains a key stock to watch. Investors will be keen on the board’s decision and its impact on share prices.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Bajaj Healthcare share price surged 10.5% on the BSE, reaching an all-time high of ₹744.9 per share. The stock rallied after the company received a recommendation from the Subject Expert Committee (SEC) (Neurology & Psychiatry) of the Central Drugs Standard Control Organisation (CDSCO) to conduct Phase III clinical trials for Cenobamate Tablets.

What is Cenobamate?

Cenobamate is an advanced anti-seizure drug used to treat partial-onset seizures in adults. It works by controlling excessive brain activity, reducing seizure frequency, and improving patient well-being.

Stock Performance & Market Data

At 1:03 PM, Bajaj Healthcare shares were up 6.2% at ₹715.6 per share on the BSE, while the Sensex was up 0.3% at 75,523.48. The company’s market value stood at ₹2,260.10 crore.

• 52-week high: ₹744.9
• 52-week low: ₹265
• 1-year gain: 124% (compared to Sensex’s 4.5% rise)

Phase III Trials and Future Plans

The company will test Cenobamate in doses of 12.5mg, 25mg, 50mg, 100mg, 150mg, and 200mg. Phase III trials are crucial as they assess a drug’s effectiveness, safety, and tolerability in a large group of patients before seeking regulatory approval. If successful, Bajaj Healthcare plans to launch Cenobamate in India and manufacture its Active Pharmaceutical Ingredient (API) in-house.

Company’s Global Presence

Founded in 1993, Bajaj Healthcare specialises in manufacturing Active Pharmaceutical Ingredients (APIs), intermediates, formulations, and nutraceuticals. It operates state-of-the-art facilities catering to both developed and emerging markets and has a strong presence in Europe, the USA, Australia, the Middle East, and South America.

Managing Director’s Statement

Anil Jain, Managing Director of Bajaj Healthcare, expressed excitement about the approval and emphasised the company’s commitment to providing high-quality epilepsy treatments.

Conclusion

With the growing demand for effective epilepsy medications, Bajaj Healthcare’s approval for Phase III trials of Cenobamate marks a significant step. The stock’s strong rally reflects investor confidence in the company’s future growth prospects.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

SpiceJet share price jumped over 4% on Wednesday after the airline announced that its promoter, Ajay Singh, had infused ₹294.09 crore into the company. This investment was made through M/s Spice Healthcare Private Limited, a Promoter Group company. Following the news, SpiceJet shares surged 4.83% to ₹50.55 on the BSE.

Completion of ₹500 Crore Investment

This latest capital infusion marks the completion of Ajay Singh’s ₹500 crore equity investment in SpiceJet. The funds were raised by converting 13.14 crore warrants into an equal number of equity shares. As a result, the Promoter Group’s stake increased from 29.11% to 33.47%, the airline revealed in a regulatory filing on March 19.

Ajay Singh, Chairman and MD of SpiceJet, stated, “This investment will strengthen our financial position, drive growth, and improve operations. We are ready to seize new opportunities and create value for customers and stakeholders.”

SpiceJet Stock Performance

• 1-Month Gain: 15%
• Year-to-Date (YTD) Loss: 10%
• 6-Month Loss: 26%
• 1-Year Loss: 15%
• 2-Year Gain: 50%

As of 12:55 PM, SpiceJet share price were trading 3.44% higher at ₹49.88 on the BSE.

Conclusion

Ajay Singh’s ₹500 crore investment strengthens SpiceJet’s financial stability and growth prospects. While the stock has seen recent gains, long-term performance remains mixed.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.